Stage-directed individualized therapy in esophageal cancer
Files
Publication date
2016-10-01
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Esophageal cancer is the eighth most common cancer worldwide, and the incidence of esophageal carcinoma is rapidly increasing. With the advent of new staging and treatment techniques, esophageal cancer can now be managed through various strategies. A good understanding of the advances and limitations of new staging techniques and how these can guide in individualizing treatment is important to improve outcomes for esophageal cancer patients. This paper outlines the recent progress in staging and treatment of esophageal cancer, with particularly attention to endoscopic techniques for early-stage esophageal cancer, multimodality treatment for locally advanced esophageal cancer, assessment of response to neoadjuvant treatment, and the role of cervical lymph node dissection. Furthermore, advances in robot-assisted surgical techniques and postoperative recovery protocols that may further improve outcomes after esophagectomy are discussed.
Keywords
anastomotic leakage, esophageal cancer, esophageal surgery, neoadjuvant chemoradiation, robot-assisted, tumor staging, General Biochemistry,Genetics and Molecular Biology, History and Philosophy of Science, Journal Article, Review
Citation
Goense, L, van Rossum, P S N, Kandioler, D, Ruurda, J P, Goh, K L, Luyer, M D, Krasna, M J & van Hillegersberg, R 2016, 'Stage-directed individualized therapy in esophageal cancer', Annals of the New York Academy of Sciences, vol. 1381, no. 1, pp. 50-65. https://doi.org/10.1111/nyas.13113